Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03834155 · ClinicalTrials.gov registry record · NA

Enhancing Cardiac Rehabilitation Through Behavioral Nudges

A NA study of Coronary Artery Disease and Acute Myocardial Infarction, sponsored by Denver Health and Hospital Authority.

Completed
Registry status
NA
Development phase
447
Enrollment target
1
Study location

NCT03834155: Completed NA study of Coronary Artery Disease and Acute Myocardial Infarction, sponsored by Denver Health and Hospital Authority.

NCT03834155 is a NA study of Coronary Artery Disease and Acute Myocardial Infarction that has completed, run by Denver Health and Hospital Authority. The registered enrollment target is 447 participants, below the 1,285-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03834155, a NA study of Coronary Artery Disease and Acute Myocardial Infarction, has completed, sponsored by Denver Health and Hospital Authority.

COMPLETED
Registry status
NA
Development phase
447 participants
Enrollment target
1
Study location

Study Summary

Adherence to cardiac rehabilitation is poor, and worse for minorities, women, and those with lower levels of education. Patients less likely to be referred to and complete cardiac rehab are at highest risk of adverse outcomes and thus have the most to gain from participation in cardiac rehab. To improve participation, healthcare systems need to limit barriers to enrollment and promote adherence to rehabilitation.

Primary Outcome

Attendance for 4 weeks (8 or more) exercise sessions for hospital-based CR or logging exercise data for 4 weeks for home-based rehabilitation.

Interventions

  • OTHER Hospital-based CR + Movn Application
  • OTHER Choice of Hospital or home-based CR + Movn Application
  • OTHER Hospital-based CR + Movn Application + Nudge
  • OTHER Choice of Hospital or home-based CR + Movn Application + Nudge

Study Locations (1)

Colorado

  • Denver Health and Hospital Authority - Denver

Trial Details

FieldValue
Enrollment Target 447 participants
Start Date 2019-05-17
Est. Completion 2024-08-31
Phase NA

What the finished NCT03834155 record still lists

NCT03834155 is an interventional study that assigns participants to a tested intervention. The registered 447 participants enrollment target is mid-sized for trials with a published cap, below the 1,285-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (65% lower).

The record links to 6 conditions, with Coronary Artery Disease appearing as the primary indexed condition, and to 4 interventions - of which Hospital-based CR + Movn Application is the first listed.

NCT03834155 reports a single indexed study location in Colorado.

Frequently Asked Questions

What is clinical trial NCT03834155 about?

NCT03834155 is a clinical study titled "Enhancing Cardiac Rehabilitation Through Behavioral Nudges". Adherence to cardiac rehabilitation is poor, and worse for minorities, women, and those with lower levels of education. Patients less likely to be referred to and complete cardiac rehab are at highest risk of adverse outcomes and thus have the most to gain from participation in cardiac rehab. To imp...

What is the current status of trial NCT03834155?

This trial is currently completed. It is a NA study. The enrollment target is 447 participants. The study started on 2019-05-17. Estimated completion is 2024-08-31.

What conditions does trial NCT03834155 study?

This clinical trial studies the following conditions: Coronary Artery Disease, Acute Myocardial Infarction, Percutaneous Coronary Intervention, Chronic Stable Angina, Valvular Disease.

What interventions are being tested in trial NCT03834155?

The interventions under investigation include: Hospital-based CR + Movn Application (OTHER), Choice of Hospital or home-based CR + Movn Application (OTHER), Hospital-based CR + Movn Application + Nudge (OTHER), Choice of Hospital or home-based CR + Movn Application + Nudge (OTHER).

Who is sponsoring clinical trial NCT03834155?

This trial is sponsored by Denver Health and Hospital Authority, which has 73 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03834155 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Coronary Artery Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03834155's enrollment target sits among peer trials

447 81st of 219 higher than 139 of 219 other Coronary Artery Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Coronary Artery Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04065399 · 447 participants · Phase 1

    A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

  • NCT06702449 · 448 participants · Phase 1

    A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy in Females 18-64 Years of Age

  • NCT07125053 · 448 participants · NA

    COPD Resources, Education, and Activity Designed for You Study

  • NCT01280994 · 445 participants · Phase 2

    Hyperpolarized 129Xe MRI for Imaging Pulmonary Function

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03834155, the US trial registry maintained by the National Library of Medicine. NCT03834155 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.